GLP-1 Agonist to Treat Obesity and Prevent Cardiovascular Disease: What Have We Achieved so Far?-Reference-Cited by-同舟云学术

GLP-1 Agonist to Treat Obesity and Prevent Cardiovascular Disease: What Have We Achieved so Far?

Published:2022-08-31 Issue:11 Volume:24 Page:867-884
ISSN:1523-3804
Container-title:Current Atherosclerosis Reports
language:en
Short-container-title:Curr Atheroscler Rep

Author:

Pedrosa Maurício Reis^ORCID,Franco Denise Reis^ORCID,Gieremek Hannah Waisberg^ORCID,Vidal Camila Maia^ORCID,Bronzeri Fernanda^ORCID,de Cassia Rocha Alexia^ORCID,de Carvalho Cara Luis Gabriel^ORCID,Fogo Sofia Lenzi^ORCID,Eliaschewitz Freddy Goldberg^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11883-022-01062-2.pdf

Reference120 articles.

1. Klein S, Gastaldelli A, Yki-Järvinen H, Scherer PE. Why does obesity cause diabetes? Cell Metab. 2022;34(1):11–20. https://doi.org/10.1016/j.cmet.2021.12.012. Recent article on adipose tissue function in obesity.

2. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet. 2011;377(9765):557–67. https://doi.org/10.1016/S0140-6736(10)62037-5.

3. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27. https://doi.org/10.1056/NEJMoa1614362.

4. Gastaldelli A, Abdul Ghani M, DeFronzo RA. Adaptation of insulin clearance to metabolic demand is a key determinant of glucose tolerance. Diabetes. 2021;70(2):377–85. https://doi.org/10.2337/db19-1152.

5. Smith GI, Mittendorfer B, Klein S. Metabolically healthy obesity: facts and fantasies. J Clin Invest. 2019;129(10):3978–89. https://doi.org/10.1172/JCI129186.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. INCIDÊNCIA DE PANCREATITE AGUDA DEVIDO AO USO DE AGONISTAS DO RECEPTOR DE GLP-1;RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218;2024-09-13

2. Analyzing the Metabolic Destiny of Potentilla discolor Bge. Extract and Its Primary Components in Rat Models;Current Pharmaceutical Analysis;2024-08-15

3. Incretin‐based therapies for the management of cardiometabolic disease in the clinic: Past, present, and future;Medicinal Research Reviews;2024-08-14

4. Efficacy and safety of glucagon-like peptide-1 receptor agonists in the treatment of polycystic ovary syndrome-A systematic review and meta-analysis;Archives of Physiology and Biochemistry;2024-07-31

5. Efficacy and safety of polyethylene glycol loxenatide in treating mild-to-moderate diabetic kidney disease in type 2 diabetes patients: a randomized, open-label, clinical trial;Frontiers in Endocrinology;2024-07-19